Navigation Links
Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
Date:3/11/2008

tions, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that survival trends will not be replicated in larger trials and the risk that the company will experience delays in patient enrollment. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007 and the quarterly report on Form 10-Q for the quarter ended January 31, 2008. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregri
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
2. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
3. Statement from American Water Works Association on Associated Press Story on Pharmaceuticals in Drinking Water
4. Vion Pharmaceuticals Regains NASDAQ Listing Compliance
5. NPS Pharmaceuticals to Report 2007 Financial Results
6. Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
7. Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results
8. Notice of Bradmer Pharmaceuticals Conference Call
9. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
10. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter 2007 Financial Results
11. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 Smile Brands Inc. ( ... business support services to dental groups in the United ... affiliated Castle Dental office in Hendersonville, TN. ... 37075, this new Castle Dental office provides families with ... latest in comprehensive, quality dental care. Hendersonville marks the ...
(Date:3/27/2015)... Hawkins, Pastor and Overseer at The House of Yahweh in ... is through the Laws of Peace written in the Holy ... article titled, “Yahweh’s Way-The Great Difference” focuses on the past ... the original biblical instructions has caused mass chaos worldwide. ... in the world is based on man-made laws that will ...
(Date:3/27/2015)... The Thomas Scattergood Behavioral ... foundation committed to raising its voice to improve ... , The Scattergood Foundation and The Kennedy Forum ... and Practice through the Annual Scattergood Foundation Innovation ... is designed to guide the IBS sufferer through ...
(Date:3/26/2015)... Alamitos, Calif. (PRWEB) March 26, 2015 ... the grocery store. Fresh produce are today’s traffic magnets. ... a particular supermarket because of their produce department, according ... important than ever as people are looking to add ... National Love Your Produce Manager® Day is April 2. ...
(Date:3/26/2015)... March 26, 2015 North American Seminars ... website is dedicated to providing information regarding OT PT ... therapy community. As a leader in live hands ... provided over 200 live and online continuing education courses. ... Education Courses :, A Master Clinicians Approach to Advanced ...
Breaking Medicine News(10 mins):Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3
... RGDX ) today announced its President and CEO, ... on its ERCC-1,molecular diagnostic gene expression test for cisplatin-based ... Diego Marriot Del,Mar in San Diego October 31 to ... Thursday, Nov. 1. The presentation will be made ...
... NOGALES, Mexico, Oct. 31 Consejo de Latinos ... educates and,assists Latinos and others, and government officials ... news conference today the launch of an,international investigative ... 1st. Immigrant "dumping" is the practice of ...
... Provides Customized Oral Chemotherapy ... ... Maximizing on the momentum gained,during Breast Cancer Awareness Month, healthcare ... cancer patients --,OralChemoAdvisor.com -- an educational, state-of-the-art Web site about,oral ...
... shows that massage therapy decreases pain levels for patients after heart ... participated in a pilot study to examine the effect of massage ... mean pain scores were less than 1 on a scale of ... the massage therapy, these patients rated their pain at an average ...
... 31 Impact,Medical Solutions, Inc. (OTC Bulletin Board: ... of Craig W. Lunsman to its board,of directors. ... of William,Jamieson Group, LLC, a consulting group that ... and private small cap companies.,As an outside director, ...
... Top-Ranked Medicaid Plan in Pennsylvania, PITTSBURGH, Oct. 31 ... for Quality Assurance (NCQA) recently released its third,report on ... Plans 2007."* Gateway Health Plan is ranked #12 among ... in Pennsylvania. "Gateway Health Plan is extremely proud ...
Cached Medicine News:Health News:Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference 2Health News:Latino Advocacy Group Investigates Immigrant 'Dumping' by U.S. Employers 2Health News:Roche Offers Innovative Website Designed to Empower Cancer Patients 2Health News:Mayo researchers: complementary therapies help patients recover after heart surgery 2Health News:Mayo researchers: complementary therapies help patients recover after heart surgery 3Health News:Impact Medical Solutions Announces Appointment of New Director 2Health News:Impact Medical Solutions Announces Appointment of New Director 3Health News:Gateway Health Plan Ranked Again Among 'America's Best Health Plans' According to U.S. News & World Report, NCQA 2
(Date:3/26/2015)... , March 26, 2015  RegeneRx Biopharmaceuticals, Inc. ... has received a patent acceptance notice from the Israeli ... (TB4) to prevent or reduce tissue damage caused by ... case when cardiac vessels are opened after a blockage ... treating stroke victims. Damage can be caused ...
(Date:3/26/2015)... Switzerland , March 26, 2015  The new ... sound from the unaidable ear to a Venture hearing aid ... single-sided deafness to hear speech from the side they could ... CROS II is as easy and intuitive as a normal ... the CROS solution during the fitting session.    ...
(Date:3/26/2015)... , March 26, 2015 InfuSystem Holdings, Inc. (NYSE ... related services for the healthcare industry in the ... announced today it has secured a new $45.0 million credit ... previous $36.5 million credit facility with its prior lender group.  ... into the new five-year senior secured credit agreement comprised of ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3Phonak CROS II: The smart solution for single-sided deafness 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4
... Purchases 933,022 shares of Common Stock at $15.00 per Share,Increases Ownership Stake to 19.9%." /> ... ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse ...
... China PharmaHub Corp. ("PharmaHub"), which has recently merged with World ... has changed its name to China PharmaHub Corp, and is ... under its new name with a new symbol, announced today ... a world leader in precision glass technology which can be ...
Cached Medicine Technology:Fosun Pharma Acquires $14 Million of Chindex Stock 2Fosun Pharma Acquires $14 Million of Chindex Stock 3Fosun Pharma Acquires $14 Million of Chindex Stock 4Fosun Pharma Acquires $14 Million of Chindex Stock 5Fosun Pharma Acquires $14 Million of Chindex Stock 6Fosun Pharma Acquires $14 Million of Chindex Stock 7Fosun Pharma Acquires $14 Million of Chindex Stock 8Fosun Pharma Acquires $14 Million of Chindex Stock 9UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh 2UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh 3UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh 4
Gerl tying forceps, titanium, with 0.12 mm teeth....
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Girard angled tying forceps made of titanium has angled 45 shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 102 mm....
Medicine Products: